

The conduct of thalassaemia-related clinical trials in Lebanon, a nation recently afflicted by armed conflict, reflects the exceptional resilience, ingenuity, and adaptability of its health-care professionals. Despite enduring an escalating threat of armed violence, clinical research in Lebanon has not only survived, but it has also evolved. This Global haematology article outlines how thalassaemia clinical trials were managed under wartime conditions at the Chronic Care Center, a specialised long-term care thalassaemia centre located in Hazmieh, Lebanon, and affiliated with the American University of Beirut in Lebanon.
Haematology
|15th Jan, 2026
|The Lancet
Haematology
|15th Jan, 2026
|The Lancet
Haematology
|15th Jan, 2026
|The Lancet
Haematology
|15th Jan, 2026
|The Lancet
Haematology
|15th Jan, 2026
|The Lancet
Haematology
|15th Jan, 2026
|The Lancet
Haematology
|31st Dec, 2025
|The Lancet